Home›Companies›Healthcare›Bioinsights

Bioinsights, Inc.

Software helps functional medicine providers analyze patient information and plan treatment.

Updated Nov 9, 2026·Latest SEC filing Sep 22, 2026·Suggest an edit

About Bioinsights

Bioinsights is a private company based in Lutz, Florida, incorporated in 2026 in Delaware. It has reported $2,747,698 raised in one offering on Form D since September 2026. Its chief executive is Travis Bond.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 13, 2026Sep 22, 2026$2,747,698of $7.8M target7$392KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bioinsights's Form D filed Sep 22, 2026.

Sources

  1. SECBioinsights, Inc. filing history